Eli Lilly's five-year trial in Greater Manchester aims to explore whether weight loss drugs can help improve the UK's unemployment crisis by enabling individuals to return to work.
UK officials emphasize that obesity-related health issues incur substantial costs to the National Health Service. The trial may provide insights into the significant impact that weight management can have on employment and economic activity.
Collection
[
|
...
]